x

Putin, Merkel discuss joint vaccine production

Russian President Vladimir Putin and German Chancellor Angela Merkel have discussed the possibility of jointly producing coronavirus vaccines in a phone call, the Kremlin said Tuesday.

“Issues of cooperation in combating the coronavirus pandemic were discussed with an emphasis on the possible prospects for joint production of vaccines,” the Kremlin said in a statement.

The Kremlin added that an agreement was reached to “continue contacts on the issue” between the two countries’ health ministries and specialised agencies.

The two leaders also discussed the settlement of the conflict between Kiev and pro-Russian separatist forces in eastern Ukraine, that has largely remained at a standstill since peace accords were signed in 2015.

Both Russia and Germany have recently started mass vaccination drives at home to curb the spread of the coronavirus and avoid reimposing nationwide lockdowns.

While Germany is using the vaccine jointly developed by Pfizer and the Mainz-based company BioNtech, Russia has put into mass circulation its homemade jab — Sputnik V.

Russia announced the registration of Sputnik — named after the Soviet-era satellite — in August, before the start of large-scale clinical trials, raising concerns over the fast-tracked procedure.

Some critics have described it as a tool to bolster Russia’s geopolitical influence.

Russia started a mass vaccination drive in early December, making the jab first available to high-risk groups including medics, teachers and the elderly.

Alexander Gintsburg, the director of the state-run Gamaleya research centre that developed Sputnik, on Tuesday said that over 1 million people in Russia have received the jab so far.

Moscow also sent batches of its vaccine to Belarus, Serbia and Argentina and announced that 2.6 million doses will be supplied to Bolivia but acknowledged that it was struggling with production capacity.

In another sign of recognition for the Sputnik jab that has been viewed with scepticism by the West, British-Swedish drugmaker AstraZeneca in December announced a clinical trial programme that would use a combination of its vaccine and the Russian one.

Both use the adenovirus vectors, although it remains unclear when these tests will go ahead.

Hot this week

Editors Urge Government To Create Safe, Enabling Environment For Journalists

· Ask security agents to find missing Vanguard journalist As...

EXCLUSIVE: Buhari orders probe of Isa Funtua, AMCON over keystone and Etisalat

Following the controversy generated by the leading opposition party,...

6 Signs your boyfriend thinks you are ugly -Take note of No. 2

They say there are three kinds of people; the...

2023: South-East, Middle Belt Forum Endorses Peter Obi

The South-East and Middle Belt Forum has endorsed the...

Court Slams Nigerian Army with ₦50m Fine Over Death of Jos Taxi Driver

By Israel Adamu, Jos A Federal High Court sitting in...

Plateau PDP Crisis: Hon. Clinton Garba Replies Hon. Bagos

...Says Matter Is a Family Affair, Not for Political...

Plateau Set to Host North-Central Public Hearing of Senate Constitution Review Committee

By Israel Adamu, Jos The Plateau State Government has announced...

North-Central Forum Endorses Al-Makura for APC National Chairman

By Israel Adamu, Jos The North-Central All Progressives Congress (APC)...

Security Above Politics: Kogi Govt Hails Faleke

...Commends Lawmaker’s Selfless Contribution to State Security By Noah Ocheni,...

Sen. Akume Holds Sway as SGF

...Purported Removal from Office Mere Disinformation By Francis Wilfred The Office...

Club World Cup: PSG Crush Messi’s Inter Miami 4-0 to Book Quarter-Final Spot

Paris Saint-Germain powered past Lionel Messi’s Inter Miami with...

Gospel Singer ‘New Jerusalem’ Dies at 53

Popular Benue gospel musician, Israel Terhemba Ikyereve, better known...
spot_img

Related Articles

Popular Categories

spot_imgspot_img